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Acinetobacter baumannii is an opportunistic pathogen causing pneumonia, respiratory
infections and urinary tract infections. The prevalence of this lethal pathogen increases
gradually in the clinical setup where it can grow on artificial surfaces, utilize ethanol as a
carbon source. Moreover it resists desiccation. Carbapenems, a β-lactam, are the most
commonly prescribed drugs against A. baumannii. Resistance against carbapenem has
emerged in Acinetobacter baumannii which can create significant health problems and
is responsible for high morbidity and mortality. With the development of quantitative
proteomics, a considerable progress has been made in the study of carbapenem
resistance of Acinetobacter baumannii. Recent updates showed that quantitative
proteomics has now emerged as an important tool to understand the carbapenem
resistance mechanism in Acinetobacter baumannii. Present review also highlights the
complementary nature of different quantitative proteomic methods used to study
carbapenem resistance and suggests to combine multiple proteomic methods for
understanding the response to antibiotics by Acinetobacter baumannii.
Keywords: quantitative proteomics, Acinetobacter baumannii , carbapenem resistance, pathogenesis, biofilm
formation
INTRODUCTION
Acinetobacter baumannii is one of the six opportunistic pathogens
grouped into ESKAPE pathogens that are linked to the highest
degree of mortality as described by Infectious Disease Society of
America (Klevens et al., 2006; Boucher et al., 2009). It causes
pneumonia, urinary tract infections, respiratory infections and
meningitis. Acinetobacter baumannii has emerged as a threat
to soldiers, wounded during military operations in Iraq and
Afghanistan (Davis et al., 2005). The organism can be isolated
from natural resources (Kempf et al., 2012). It can grow on arti-
ficial surfaces (Espinal et al., 2012) and can utilize ethanol as
a carbon source (Navon-Venezia et al., 2005; Fiester and Actis,
2013; Gandhi et al., 2014), resist desiccation, survive at various
temperature and pH conditions (Bergogne-Berezin and Towner,
1996), this makes it a lethal pathogen. Prevalence of Acinetobacter
baumannii in clinical setup has increased gradually (Tiwari et al.,
2012a). Commonly prescribed drug against A. baumannii are
carbapenems which belong to the β-lactam group of antibiotics
(Hawkey and Jones, 2009). Resistance against carbapenem has
emerged in Acinetobacter baumannii which can create significant
health problems and responsible for high morbidity and mortal-
ity (Sengstock et al., 2010). Reports showed that mortality due
to carbapenem-resistant Acinetobacter baumannii is about 52% as
compared to 19% when infected with carbapenem sensitive vari-
ant (Jamulitrat et al., 2009). This makes it one of the major health
concerns.
Quantitative proteomics has been employed for both discovery
and targeted proteomic analysis to understand global proteomic
dynamics of the organism. With the development of quantitative
proteomics, a considerable progress has been made in the study
of drug resistance. There are various methods which are used in
the quantitative proteomics. Oldest method is the comparison
of two commassie stained 2D-PAGE gels (Klose, 1975; O’farrell,
1975; Meleady, 2011; Rabilloud and Lelong, 2011). This was fol-
lowed by emergence of labeled method like Differential In-Gel
Electrophoresis, DIGE (Unlu et al., 1997; Yan et al., 2002; Knowles
et al., 2003; Timms and Cramer, 2008), Stable Isotope Labeling
by Amino acids in Cell culture, SILAC (Ong et al., 2002; Ong and
Mann, 2005) Isotope Coded Affinity Tags, ICAT (Gygi et al., 1999;
Gygi and Aebersold, 2000), Isobaric tags quantification, iTRAQ
(Ross et al., 2004; Desouza et al., 2009) and Isotope-coded protein
label, ICPL (Kellermann, 2008; Abdallah et al., 2012; Kellermann
and Lottspeich, 2012). Isotope labels can be introduced into pep-
tides metabolically, chemically or enzymatically. Most recently
developed methods for quantitative proteomics are label free
quantification methods like spectral counting (Mirza and Olivier,
2008; Zhu et al., 2010) and Selected Reaction Monitoring, SRM
(Elschenbroich and Kislinger, 2011; Hossain et al., 2011). In label
free proteomic methods, mass spectrometer can recognize the
mass difference and their quantification is achieved by compar-
ing their respective signal intensities. Proteomic techniques have
been used for the identification and quantification of protein
samples and its validation have been done by ELISA (Chen et al.,
2010), western blotting (Xiaoyu et al., 2013), immunohistochem-
istry (Perdomo et al., 2012), RT-PCR and real time PCR (Choi
and Shim, 2008; Zhang et al., 2011; Paul et al., 2013; Xiaoyu
et al., 2013). In the present review, we critically review the use of
quantitative proteomics in the study of carbapenem resistance in
Acinetobacter baumannii. We also discuss the future perspective of
the quantitative proteomics in the study of carbapenem resistance
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as well as limitation of different methods used in quantitative
proteomics.
QUANTITATIVE PROTEOMICS AS A TOOL TO STUDY OF
CARBAPENEM RESISTANCE IN A. BAUMANNII
Quantitative proteomics has very diverse applications and signifi-
cance but in the present review, we have explained its significance
in the study of carbapenem resistance of Acinetobacter bauman-
nii. A number of approaches using quantitative proteomics have
been employed for the study of bacterial drug resistance and
pathogenesis.
Quantitative outer membrane proteomics between wild type
and carbapenem resistance strain of Acinetobacter baumannii
have been reported (Marti et al., 2006; Siroy et al., 2006; Kwon
et al., 2009). Using silver stained 2DE gel, selection of protein
spots based on the intensity and sharpness of the spots in the
gel; and identification of the protein by homologous matching
with other species of Acinetobacter, Marti et al., performed an
analysis of the major proteins in the membrane fraction of a
multidrug resistant strain of Acinetobacter baumannii and iden-
tify OmpA, ribosomal protein, chaperone and elongation factor
(Marti et al., 2006). The result does not highlight the quantita-
tive expression of protein but it signifies the application of the
proteomics in the study of carbapenem resistance. Siroy et. al.,
performed global comparison of the membrane fraction of a sen-
sitive strain with a carbapenem resistant strain of Acinetobacter
baumannii by comparing two coomassie stained 2D-PAGE gels.
Results highlighted that about 36 and 56% protein spots were
different in the inner membrane and outer membrane fraction
of resistant strain of Acinetobacter respectively as compared to
the sensitive strain (Siroy et al., 2006). They pointed out that
resistance against carbapenem has been developed due to over-
expression of RND-type efflux systems and virulence factors like
FepA-like and siderophore receptors, absence of PBP1b protein,
structural modifications to the CarO porin and presence of differ-
ent isoforms of the channel OmpW in the carbapenem resistant
strain of Acinetobacter baumannii (Siroy et al., 2006). This study
has given a new direction to the study of carbapenem resistance
using quantitative proteomics approach. Similar to approach of
Marti et al. (2006), Kwon et al., also used silver stained 2DE
gel to identify 132 proteins associated with outer membrane
vesicles of Acinetobacter baumannii (Kwon et al., 2009). 2D elec-
trophoresis was also used to explain role of different proteins in
metabolism using native ATCC strain of Acinetobacter baumannii
(Soares et al., 2009b). Results highlighted that robust and ver-
satile metabolism of Acinetobacter plays very important role in
the carbapenem resistance and virulence of A. baumannii (Soares
et al., 2009b). Using 2DE based membrane proteomic approach;
Lee et al., explained the mechanism of hetero-resistance induced
by imipenem (a member of carbapenem group) in the multidrug
resistant Acinetobacter baumannii (Lee et al., 2011). They showed
that imipenem treatment leads to the up-regulation of AmpC,
Cpn60 chaperonin, ATP synthase, and OmpA (Lee et al., 2011).
Vashist et al., showed the importance of outer membrane in
the carbapenem resistance using differential DIGE of outer mem-
brane of carbapenem resistance strain as compared to sensitive
strain of Acinetobacter (Vashist et al., 2010). They concluded
that emergence of carbapenem resistance in A. baumannii is due
to the decreased expression of CarO, porins (e.g., Omp-A) and
increased expression of biofilm forming protein (e.g., CsuA/B)
and nutrient transporters (e.g., iron binding protein, ABC trans-
porter). Vashist et al., identified more proteins with significant
role in the carbapenem resistance of Acinetobacter as compare
to Siroy et al. (2006), which further confirm the advantages of
DIGE based methods (Vashist et al., 2010) over silver stained
methods (Siroy et al., 2006). Similarly, Tiwari et al., identified the
importance of the metabolism in the carbapenem resistance of
Acinetobacter using differential DIGE of inner membrane frac-
tion (Tiwari et al., 2012c). Results concluded that emergence
of carbapenem resistance in A. baumannii was found to be
associated with overproduction of carbapenem hydrolysing β-
lactamase (e.g., AmpC and OXA-51) and metabolic enzymes as
well as downregulation of surface antigen and OmpW. They also
showed that overproduction of these proteins/enzymes have been
achieved by enhanced transcription, translation (e.g., Elongation
factor Tu and 30S ribosomal protein) and folding (e.g., 60 KDa
chaperonin and TCP-1/cpn60 chaperonin protein (Tiwari et al.,
2012c).
Yun et al., performed differential quantitative proteomic
analysis of cell wall and plasma membrane fractions from
multidrug-resistant Acinetobacter baumannii using labeled
iTRAQ quantitative approach (Yun et al., 2011). They reported
that carbapenem also induces the expression of resistance-
nodulation-cell division transporters, protein kinases and
suppresses outer membrane proteins expression (Yun et al.,
2011). This study further advanced the study of carbapenem
resistance of Acinetobacter baumannii because it used isobaric tag
for labeling, reverse phase chromatography for peptide separa-
tion and MS/MS mass spectrometry for peptide identification
which was relatively more sensitive than older methods. They
also compared the result from label as well as label free methods
and concluded that more than 80% protein have similar expres-
sion (down/up-regulation) pattern for label-free (LC-MS/MS)
and labeled (iTRAQ) methods (Yun et al., 2011). This result
highlighted the importance to use more than one quantitative
proteomic method because of their complementary nature to
enhance the reproducibility and validity of quantitative pro-
teomic result. The identified proteins from different quantitative
proteomic methods have been listed in the Table 1.
Pathogenesis of the Acinetobacter is also influenced by host-
pathogen interaction and nutritional immunity of the host. Role
of nutritional immunity in the survival of carbapenem resistance
strain of Acinetobacter in human host has also been studied using
differential proteomic approach (Nwugo et al., 2011; Mortensen
and Skaar, 2012; Tiwari, 2013). Nwugo et al., compare the 2DE
gel of total lysate and outer membrane fractions isolated from
A. baumannii sensitive strain cultured under iron-rich and iron-
deficient condition. Results indicated that iron-rich condition
leads to the overexpression of proteins involved in the iron stor-
age, metabolic process and lipid biosynthesis while iron deficient
condition leads to the overexpression of proteins involved in
the iron acquisition (Nwugo et al., 2011). Similarly, using DIGE
and LC-MS/MS, Tiwari et al., concluded that carbapenem resis-
tant strain of A. baumannii upregulates proteins associated with
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Table 1 | Differentially expressed proteins identified in the carbapenem resistance strain as compared to sensitive strain of A. baumannii using
various quantitative proteomic approaches (Siroy et al., 2006; Kwon et al., 2009; Vashist et al., 2010; Cabral et al., 2011; Lee et al., 2011;
McQueary and Actis, 2011; Yun et al., 2011; Tiwari et al., 2012c).
Identified Protein Quantitative Proteomic methods Significance
2DE DIGE Isobaric and other
Carbapenem hydrolyzing beta-lactamase (AmpC
and OXA)
Yes Yes Yes Hydrolyze beta-lactams and carbapenem
Efflux pumps (AdeABC efflux pump, RND Family
transporters)
Yes Yes Yes Aids in the efflux of the antibiotics
Penicillin-binding protein (PBP6, PBP1b) Yes No Yes Synthesis of peptidoglycan, its alteration cause
resistance
Outer membrane protein (OmpA) No Yes Yes Associated with non-specific transport
CarO protein Yes Yes Yes Involved in carbapenem resistance
Omp W Yes Yes Yes Down regulation in resistant strains decreases entry of
antibiotics
Biofilm forming protein (Csu A/B) Yes Yes Yes CsuA/BABCDE chaperone-usher pili assembly system
is require for biofilm formation
DcaP like protein No Yes Yes Associated with cell wall and membrane biogenesis,
also have role in biofilm formation
Putative porin, OprD family No Yes Yes Involved in non-specific transport, also have role in
biofilm formation
Signaling protein (tyrosine kinase) N/D N/D Yes Involved in novel two-component regulatory system
which plays role in biofilm formation
Iron-binding protein Receptor (Siderophore
receptor)
No Yes Yes Involved in iron transport
Chaperonin No Yes Yes Aids in stress induced stabilization of protein
Peptidyl-prolyl cis-trans isomerase N/D Yes Yes Accelerates the folding of proteins by cis-trans
isomerization of proline imidic peptide bonds
Regulatory protein (Elongation Factor Tu etc.) Yes Yes Yes Associated with protein synthesis
Energy producing enzymes (MDH, Aconitate
hydratase, ATP synthase etc.)
No Yes Yes Associated with energy production in the cell
Putative tonB-dependent receptor protein Yes N/D Yes Acts as TonB-dependent receptor for a non-iron
nutrient source
ABC transporter Yes Yes Yes Associated with Phosphate and Amino acid transport
Lipoproteins Yes Yes Yes Involved in the adhesion and translocation of virulence
factors in host cells
Superoxide dismutase Yes Yes Yes Destroy free radicals produced in the cell
Phosphor-N-acetyl muramoylpentapeptide
Transferase
N/D N/D Yes Involved in Cell wall synthesis
Cell division protein (zipA) N/D N/D Yes Involved in cell division
Putative universal stress protein family N/D N/D Yes Involved in the stress response
No, No change; Yes, changed in the resistant strain as compared to sensitive strain; N/D, Not detected.
iron acquisition under iron limiting condition while upregulate
metabolic enzymes under iron limiting condition (Tiwari, 2013).
High-end isoelectric point (pH 6–11) differential proteome
analysis of Acinetobacter radioresistens also reveals that envelope
stress responses can be induced by aromatic compounds (Mazzoli
et al., 2011). Role of proteins detected by the quantitative pro-
teomics methods has been validated by other in-vitro or in-vivo
methods. It was found that Acinetobacter baumannii develop
resistance against carbapenem via alteration in the expres-
sion/activity of β-lactamase (Tiwari et al., 2012a,b,c; Tiwari, 2013,
2014; Tiwari and Moganty, 2013, 2014) and alteration in the
penicillin binding protein (Vashist et al., 2011). Upregulation
of metabolic enzymes/proteins found in the inner membrane
protein also enhanced the carbapenem resistance in A. baumannii
(Tiwari et al., 2012c).
Biofilm is a functional consortium of microorganisms orga-
nized within an extensive exopolymeric matrix (Gurung et al.,
2013). Biofilm formation is one of the important causes for the
persistence of Acinetobacter baumannii on the surface of host
epithelial cells and other surfaces (Espinal et al., 2012; Longo
et al., 2014). Cabral et al., performed differential proteomics of
Acinetobacter cultured in three different conditions (exponen-
tial, late stationary phase and biofilms stage) using 2D-DIGE and
MALDI-TOF/TOF as well as iTRAQ/SCX-LC-MS/MS. They also
checked the effects of biofilm inhibitory compound (salicylate) on
the biofilm formation. This multiple-approach strategy showed
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a unique lifestyle of A. baumannii involved in biofilm forma-
tion (Cabral et al., 2011). CsuA/BABCDE chaperone-usher pili
assembly system have been identified in Acinetobacter as essen-
tial for biofilm formation on plastic (McQueary and Actis, 2011).
OmpA and CarO have role in the uptake of amino acid hence
also have role in biofilm formation by Acinetobacter baumannii
(Cabral et al., 2011).
Acinetobacter baumannii OMV’s induces pathogenesis in the
host because of secretion of the outer membrane protein (Kwon
et al., 2009) which is cytotoxic to the host (Jin et al., 2011).
Secretion of OMVs from A. baumannii has been studied using sil-
ver stained 2DE based quantitative proteomics approach (Kwon
et al., 2009). Soares et al., identified alterations in the plasma
proteome of individuals infected with Acinetobacter baumannii
as compared to healthy controls using DIGE based differential
proteomic approach (Soares et al., 2009a).
Using quantitative phosphoproteomics approach, selected
phosphorylation sites have been identified in Acinetobacter which
has been discussed in the context of stress/starvation, pathogenic-
ity and drug resistance (Soares et al., 2014). Qualitative compari-
son between the Ser/Thr/Tyr phosphoproteomes employed SCX
and TiO2 chromatography for enrichment of phosphopeptide
and LTQ-Orbitrap mass spectrometric analysis for phosphopep-
tide identification. The percentage distribution of Ser/Thr/Tyr
phosphorylation was found to be 68.9% for serine, 24.1% for
threonine and 5.2% for tyrosine in sensitive strain as compared
to 70.8% for serine, 25.2% for threonine and 3.8% for tyrosine
in carbapenem resistant strain of A. baumannii (Soares et al.,
2014). Phosphoproteomics identified 70 phosphoproteins in the
multidrug resistant strain (AbH12O-A2) of A. baumannii as com-
pared to 41 phosphoproteins in the sensitive strain (ATCC 17978)
of Acinetobacter (Soares et al., 2014). Identified phosphopro-
teins play role in the pathogenesis (e.g., PtK), virulence (e.g.,
KdpD/KdpE) and drug resistance (Soares et al., 2014). PtK sig-
nificantly enhances the ability of Acinetobacter to grow in human
biofluids. KdpD/KdpE, a bacterial two-component signal trans-
duction system, have role in the virulence-related regulatory func-
tions (Soares et al., 2014). This study highlight the significance
of high throughput quantitative methods for the study of signal-
ing associated with carbapenem resistance strain of Acinetobacter
baumannii.
Induction of proteins associated with signaling, putative viru-
lence factors and various stress responses at different stages of in-
vitro growth has been identified using growth phase-dependent
quantitative proteomics using 2-DE and MALDI-TOF/TOF com-
plemented by iTRAQ and LC-MS/MS (Soares et al., 2010; Fiester
and Actis, 2013). This result further highlighted the significance
of multiple quantitative approaches used together. Extracellular
proteome of Acinetobacter baumannii has been characterized
using 2DE and nanoLC-MS/MS based quantitative proteomic
approach (Mendez et al., 2012). Mendez et al., used two pro-
tein fractions of the extracellular proteome i.e., outer membrane
vesicle (OMV) proteins and freely soluble extracellular proteins
(FSEPs) present in the culture medium of A. baumannii. The
result showed that OMV proteins were found to be associated
with pathogenesis and virulence (e.g., CsuE, CsuB, CsuA/B) and
secretion systems for delivery of virulence factors while FSEP
fraction have extracellular enzymes with degradative activity and
role in oxidative stress response (Mendez et al., 2012).
Proteomic experiments also identified differentially expressed
lipoproteins as well as proteins responsible for inflamma-
tory/coagulation pathways and kallikrein-kinin system of
Acinetobacter which will improve future developments in
the pathogenesis of the Acinetobacter and its therapy (Soares
et al., 2009a). In quantitative immunoproteomic approach,
potentially immunogenic proteins in A. baumannii have been
identified using 2DE and MALDI-TOF/TOF mass spectrometric
analysis. Immunogenic proteins could serve as antigen for the
development of vaccines and passive immunotherapies against
A. baumannii infections (Bonin et al., 2014).
LIMITATION OF DIFFERENT QUANTITATIVE PROTEOMIC
METHODS AND THEIR SIGNIFICANCE IN THE CARBAPENEM
RESISTANCE STUDIES
There are number of limitations of quantitative proteomic meth-
ods that hamper the study of the carbapenem resistance mecha-
nism of Acinetobacter baumannii. Merits and demerit of different
methods used in the quantitative proteomics have been listed in
the Table 2.
Table 2 showed that most of the methods used in quan-
titative proteomics did not provide information about post-
translational modification and they are unable to detect the small
proteins. These two limitations can cost heavily in the stud-
ies of carbapenem resistance. Quantitative proteomics is unable
to produce all information required to confirm role of pro-
tein/biomolecule in carbapenem resistance but it gives global
insights about resistance mechanism of Acinetobacter bauman-
nii which helps in the subsequent studies. Quantitative pro-
teomic methods are also unable to give direct confirmation of
the role of protein in the carbapenem resistance. Similarly the
result of quantitative proteomics is also influenced by protein
extraction procedure. These limitations conclude that quantita-
tive proteomics help to a large extent in the study of carbapenem
resistance but it requires help of other methods for confirma-
tion. Therefore, we can say that emergence of quantitative pro-
teomics is really an added advantage in the study of carbapenem
resistance.
FUTURE PERSPECTIVES OF QUANTITATIVE PROTEOMICS TO
UNDERSTAND CARBAPENEM RESISTANCE
Fluorescence based DIGE methods and isobaric based iTRAQ
methods in combination with LC-MS/MS are more popular
approach used to study carbapenem resistance mechanism of
A. baumannii. Phosphoproteomics and immunoproteomics have
also emerged to understand virulence and pathogenesis of car-
bapenem resistant strain of A. baumannii. Every proteomic
method has its own merits and demerits (Table 2) but they
provide complementary information. Therefore, combining mul-
tiple methods together is an added advantage. This approach
has been recently used by some groups to produce valid results
(Cabral et al., 2011; Yun et al., 2011). Literature based on
proteomic methods has showed the presence of differentially
expressed proteins in the carbapenem resistant strain but their
actual role in carbapenem resistance has not been confirmed
Frontiers in Microbiology | Antimicrobials, Resistance and Chemotherapy September 2014 | Volume 5 | Article 512 | 4
Tiwari and Tiwari Quantitative proteomics of Acinetobacter baumannii
Table 2 | Different quantitative proteomic approaches with its merits and demerits.
Proteomic Tools Merits Demerits References
GEL-BASED METHODS
2DE (1) Simplistic
(2) Robust
(3) Suitable for MS analysis
(1) Involve large amount of sample
(2) Low throughput
(3) Poor recovery of hydrophobic proteins
(4) High inter-gel variability
Klose, 1975; O’farrell, 1975;
Meleady, 2011; Rabilloud and
Lelong, 2011
2D-DIGE (1) Multiplexing
(2) Better quantitation
(3) Minimized gel to gel variation
(1) Expensive Cy dyes
(2) Poor recovery of hydrophobic proteins
(3) Difficulty in separation of low molecular
weight
Unlu et al., 1997; Yan et al., 2002;
Knowles et al., 2003; Timms and
Cramer, 2008; Chen et al., 2010
GEL-FREE METHODS
SILAC (1) High throughput
(2) Robust
(3) Sensitive and simple
(1) Suitable only for tissue culture models
(2) Costly reagents
(3) Not applicable to tissue sample
Ong et al., 2002; Ong and Mann,
2005; Elliott et al., 2009
ICAT (1) Selectively isolates peptide
(2) Compatible with any amount
of protein
(3) Complexity of the peptide
mixture is reduced
(1) Cannot identify proteins with less than
8 cysteines
(2) Size of ICAT label is large (≈500Da)
(3) Post-translational modification
information is frequently lost
Gygi et al., 1999; Gygi and
Aebersold, 2000; Toyo’oka, 2012
iTRAQ (1) Applicable to versatile samples
(2) Multiplexing
(3) Better quantitation
(1) Involve high amount of sample
(2) Incomplete labeling
(3) Expensive reagents
Ross et al., 2004; Desouza et al.,
2009
ICPL (1) High-throughput quantitative
proteome profiling on a global
scale
(2) Able to detect
post-translational modifications
and protein isoforms
(3) Applicable to protein sample
like extracts from tissues or body
fluids
(1) Isotopic effect of deuterated tags that
interferes with retention time of the
labeled peptides during LC
Kellermann, 2008; Abdallah et al.,
2012; Kellermann and Lottspeich,
2012
Label-free (1) Involve less amount of sample
(2) Higher proteome coverage
(3) Avoid labeling
(1) High throughput instrumentation
(2) Not suitable for low abundant proteins
(3) Incomplete digestion may introduce
error
(4) Multiplexed analysis is not possible in
one experiment
Mirza and Olivier, 2008; Zhu
et al., 2010
SRM (1) Highly sensitive, quantitatively
accurate and highly reproducible
(2) Protein detection is relatively
rapid and straightforward
(3) Enable the detection of low
(>10 ng/ml) abundance proteins
(4) Quantification of
post-translational modification
(1) Limited broad scale application
because of difficulty of generating
high-quality SRM assay.
(2) Sensitivity is not comparable to
immunological assays
(3) Detection and quantification of low
abundance proteins (i.e., ∼10 ng/ml or
less)
Elschenbroich and Kislinger, 2011;
Hossain et al., 2011
using knockout or auxotroph for resistance factors. Therefore,
quantitative proteomic methods also require support from non-
proteomic methods. With the development of the quantita-
tive immunoproteomics, phosphoproteomics and other omics
methods, the identification of the differentially expressed resis-
tance factors become more reliable. Emergence of quantitative
proteomic methods like ICPL and SRM methods will help to
remove the shortcoming of the routinely used present methods.
Future of quantitative proteomics will depend on the use of two
quantitative proteomic methods together with better validation
methods to outcome the limitation of the current methods or
approach.
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CONCLUSIONS
The quantitative proteomics has overcome some of the limita-
tions of other approaches for investigating carbapenem resistance.
With the development in the quantitative proteomics, new oppor-
tunities are now open to study difficult and challenging tasks.
Because of complementary nature of different quantitative pro-
teomic methods, it has been suggested to combine multiple
quantitative proteomic methods for the better understanding of
carbapenem resistance in Acinetobacter baumannii.
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